When psoriasis manifests in palmoplantar and intertriginous regions or on the nails, this often poses a therapeutic challenge. Several recently presented analyses on the effects of anti-IL-23p19 antibodies currently approved for psoriasis focused on patient populations with infestation of these difficult-to-treat body regions.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Results of a systematic review and meta-analysis
Physical activity as a therapeutic approach for depression and anxiety disorders
- Underestimated risk - findings from a US cohort
Heart failure after myocardial infarction
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- From symptom to diagnosis
Abdominal pain – Sprue
- Case Report
76-year-old patient with pustular skin rash
- Sponsored Content: Psoriasis
Dauerhafte Erscheinungsfreiheit auch bei betroffenen speziellen Hautarealen
- Antithymocyte globulin in children with T1D
Old medicine, new hope
- Ginkgo biloba